Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?

Int J Cardiol Heart Vasc. 2019 Apr 15:23:100360. doi: 10.1016/j.ijcha.2019.100360. eCollection 2019 Jun.

Authors

Dominik Linz¹, Dobromir Dobrev²

Affiliations

¹ Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.
² Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.

No abstract available

Publication types

Editorial

Grants and funding